Facilitating Access to Cross-Border Supplies of Patented Pharmaceuticals: The Case of the COVID-19 Pandemic

32Citations
Citations of this article
64Readers
Mendeley users who have this article in their library.

Abstract

The COVID-19 pandemic has brought into stark relief the gaps in global preparedness to address widespread outbreaks of deadly viral infections. This article proposes legal mechanisms for addressing critical issues facing the international community in terms of providing equitable access to vaccines, treatments, diagnostics, and medical equipment. On the supply side, the authors propose the establishment of mandatory patent pools ('Licensing Facilities') on a global or regional, or even national basis, depending upon the degree of cooperation that may be achieved. The authors also discuss the importance of creating shared production facilities. On the demand side, the authors propose the establishment of Regional Pharmaceutical Supply Centers (RPSCs) for the collective procurement of products, and the need to coordinate the issuance of necessary compulsory licenses for production and/or importation, depending on relevant circumstances. The authors envisage that centralized coordination by RPSCs should assist in overcoming difficulties individual countries may encounter in addressing administrative and technical issues in procuring supplies, as well as creating improved bargaining leverage with potential suppliers. The authors finally address the problem created by the decision of various high-income countries to 'opt out' as eligible importing countries under the World Trade Organization TRIPS Agreement Article 31bis amendment that addresses the predominant export of pharmaceutical products under compulsory licenses.

References Powered by Scopus

The Doha Declaration on the TRIPS Agreement and Public Health: Lighting a dark corner at the WTO

152Citations
N/AReaders
Get full text

Disease X: accelerating the development of medical countermeasures for the next pandemic

117Citations
N/AReaders
Get full text

The Doha round's public health legacy: Strategies for the production and diffusion of patented medicines under the amended TRIPS provisions

114Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Global access to COVID-19 vaccines: A scoping review of factors that may influence equitable access for low and middle-income countries

51Citations
N/AReaders
Get full text

Equitable Access to COVID-19 Vaccines: Cooperation around Research and Production Capacity Is Critical

17Citations
N/AReaders
Get full text

Vaccine politics: Law and inequality in the pandemic response to COVID-19

14Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Abbott, F. M., & Reichman, J. H. (2020). Facilitating Access to Cross-Border Supplies of Patented Pharmaceuticals: The Case of the COVID-19 Pandemic. Journal of International Economic Law, 23(3), 535–561. https://doi.org/10.1093/jiel/jgaa022

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 17

71%

Professor / Associate Prof. 3

13%

Researcher 3

13%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Social Sciences 14

58%

Business, Management and Accounting 5

21%

Pharmacology, Toxicology and Pharmaceut... 3

13%

Medicine and Dentistry 2

8%

Save time finding and organizing research with Mendeley

Sign up for free